Ribosomal Translation and Display Selection of Cyclic Glycopeptides through Genetic Reprogramming

A robust method for the ribosomal incorporation of glycosyl-amino acids through the flexizyme-mediated reprogramming of initiating AUG codons with glycosyl-dipeptides is described. This reprogramming strategy was applied to <i>in vitro</i> mRNA display for the <i>de novo</i> discovery of α-l-fucosylated cyclic peptide inhibitors of P-selectin with antiplatelet-monocyte aggregation activity, and β-d-N-acetylgalactosamine-containing cyclic glycopeptide agonists of the asialoglycoprotein receptor (ASGPR) with potent lysosome trafficking activity. This work provides a powerful platform for the <i>de novo</i> discovery of glycopeptide ligands and expands genetic reprogramming capabilities to large modifications previously intractable for ribosomal translation.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2026-03-04
DOI
https://doi.org/10.1021/jacs.5c22682
Primary Topic
RNA and protein synthesis mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ribosomal Translation and Display Selection of Cyclic Glycopeptides through Genetic Reprogramming

Arthur H. Tang, Daniel Ford, Toby Passioura, James G. Burchfield et al.
Journal of the American Chemical Society
RNA and protein synthesis mechanisms
article

Ribosomal Translation and Display Selection of Cyclic Glycopeptides through Genetic Reprogramming

Arthur H. Tang, Daniel Ford, Toby Passioura, James G. Burchfield, Leo Corcilius, Douglas G. Johns, Yichen Zhong, José Perdomo, Lucas Kambanis, Walter Ferreira Becker, Beiyuan Cui, Caitlin E. Clarke-Shepperson, Christopher Lehmann, Ka Hin Toby Mak, Bernardo Cavallazzi Sebold, Jason Johansen-Leete, Richard J. Payne
article en

Abstract

A robust method for the ribosomal incorporation of glycosyl-amino acids through the flexizyme-mediated reprogramming of initiating AUG codons with glycosyl-dipeptides is described. This reprogramming strategy was applied to <i>in vitro</i> mRNA display for the <i>de novo</i> discovery of α-l-fucosylated cyclic peptide inhibitors of P-selectin with antiplatelet-monocyte aggregation activity, and β-d-N-acetylgalactosamine-containing cyclic glycopeptide agonists of the asialoglycoprotein receptor (ASGPR) with potent lysosome trafficking activity. This work provides a powerful platform for the <i>de novo</i> discovery of glycopeptide ligands and expands genetic reprogramming capabilities to large modifications previously intractable for ribosomal translation.

Journal of the American Chemical SocietyVol. 148(10)
The University of Sydney (AU), Australian Research Council (AU), Harry Perkins Institute of Medical Research (AU), The Heart Research Institute (AU), Analytical Services (US), Yale University (US), ARC Centre of Excellence for Innovations in Peptide and Protein Science (AU), Central Clinical Hospital (PL)
Zero hunger
Openalex Percentile: Top 34%
RNA and protein synthesis mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.